Digest Network Come funziona
Network
/
Società
De
Non verificato

Devonian Health Group Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaFinanzaMedicina - VarieSalute

24 comunicati stampa

Guarda tutti i comunicati
22/08/2025
Farmaceutica
Salute
Medicina - Varie
Finanza
Devonian Provides Corporate Update and Additional Information Regarding its Previously Announced Private Placement
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
08/08/2025
Salute
Sanità
Scienza
Farmaceutica
Devonian Announces Closing of a Private Placement of Units
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
26/06/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Mercato azionario
Devonian Health Group Reports Third Quarter 2025 Financial Results
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
09/06/2025
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Finanza
Devonian Appoints New Officers and Announces Grant of Stock Options
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
28/04/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Devonian Health Group Announces Reinstatement of Quotation on the TSXV
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
15/04/2025
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Devonian Health Group Reports Second Quarter 2025 Financial Results
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
15/04/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Devonian Health Group Reports Cease Trade Order
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
01/04/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Devonian Reports Delay of Financial Reporting
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
24/03/2025
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Devonian Reports Results of its Annual General and Special Meeting of Shareholders
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0
19/02/2025
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Devonian Announces the Filing of a New Patent Application Relating to the Use of Thykamine™ as an Antifibrotic Agent
Fonte
Devonian Health Group Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0